Valuation : MRI Interventions Inc

Market Cap 44Cr 38Cr 35Cr 32Cr 60Cr 4.12TCr 61Cr 419.99Cr 162.99Cr 2.11TCr 163.92Cr 160.33Cr 6.93TCr P/E 2026 *
-11x
P/E 2027 * -12x
Enterprise Value 44Cr 38Cr 35Cr 32Cr 60Cr 4.12TCr 61Cr 419.99Cr 162.99Cr 2.11TCr 163.92Cr 160.33Cr 6.93TCr EV / Sales 2026 *
8.91x
EV / Sales 2027 * 7.72x
Free-Float
94.56%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 49 07/11/2017
Director of Finance/CFO 41 01/01/2021
Chief Tech/Sci/R&D Officer - 01/01/2026
Director TitleAgeSince
Director/Board Member 68 10/03/2014
Chairman 80 04/02/2021
Director/Board Member 49 07/11/2017
Change 5-day change 1-year change 3-year change Capi.($)
-5.04%-33.93% - - 45Cr
+1.34%-3.97%+24.82%+9.21% 22TCr
+1.44%-2.53%+3.00%-20.96% 15TCr
+0.71%+0.39%-20.72%+19.80% 13TCr
+0.60%+0.42%-54.65%-9.79% 6.97TCr
+0.09%+0.04%+11.07%+18.91% 5.23TCr
+0.41%+0.51%-14.70%-13.84% 5.07TCr
+0.97%-2.38%+20.91%+24.18% 4.23TCr
+1.57%-0.48%+39.03%+46.68% 3.99TCr
-0.21%-2.05%-14.80%+45.03% 3.34TCr
Average +0.19%-1.55%-0.67%+13.25% 8.74TCr
Weighted average by Cap. +0.97%-2.12%+1.55%+7.08%

Financials

2026 *2027 *
Net sales 4.9Cr 4.23Cr 3.98Cr 3.63Cr 6.78Cr 462.88Cr 6.83Cr 47Cr 18Cr 236.66Cr 18Cr 18Cr 777.4Cr 5.66Cr 4.88Cr 4.6Cr 4.19Cr 7.83Cr 534.2Cr 7.89Cr 54Cr 21Cr 273.12Cr 21Cr 21Cr 897.19Cr
Net income -3.96Cr -3.41Cr -3.21Cr -2.93Cr -5.47Cr -373.61Cr -5.51Cr -38Cr -15Cr -191.02Cr -15Cr -15Cr -627.48Cr -3.88Cr -3.34Cr -3.15Cr -2.87Cr -5.36Cr -366.05Cr -5.4Cr -37Cr -14Cr -187.15Cr -15Cr -14Cr -614.78Cr
Net Debt - -
Logo MRI Interventions Inc
ClearPoint Neuro, Inc. is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The Company provides clinical products and preclinical development services for controlled drug and device delivery. Its business consists of two components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. The primary applications for the ClearPoint system are to target and guide the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, and the infusion of pharmaceuticals into the brain. It provides consulting services to its pharmaceutical and other medical technology partners.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-